IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 3 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $308,000 | -23.2% | 233,680 | +7.2% | 0.00% | 0.0% |
Q1 2018 | $401,000 | -14.5% | 218,035 | -2.0% | 0.00% | 0.0% |
Q4 2017 | $469,000 | +23.1% | 222,373 | +30.0% | 0.00% | 0.0% |
Q3 2017 | $381,000 | +15.8% | 171,055 | -10.6% | 0.00% | 0.0% |
Q2 2017 | $329,000 | -34.7% | 191,293 | -6.3% | 0.00% | 0.0% |
Q1 2017 | $504,000 | +57.5% | 204,193 | -4.3% | 0.00% | 0.0% |
Q4 2016 | $320,000 | -33.6% | 213,393 | +13.3% | 0.00% | 0.0% |
Q3 2016 | $482,000 | +68.5% | 188,393 | +0.9% | 0.00% | 0.0% |
Q2 2016 | $286,000 | -21.2% | 186,693 | +1.9% | 0.00% | 0.0% |
Q1 2016 | $363,000 | -25.8% | 183,215 | +15.7% | 0.00% | 0.0% |
Q4 2015 | $489,000 | -6.1% | 158,365 | +1.8% | 0.00% | 0.0% |
Q3 2015 | $521,000 | -10.0% | 155,604 | -0.3% | 0.00% | 0.0% |
Q2 2015 | $579,000 | -0.5% | 156,104 | -0.5% | 0.00% | 0.0% |
Q1 2015 | $582,000 | +18.8% | 156,906 | +41.2% | 0.00% | 0.0% |
Q4 2014 | $490,000 | +93.7% | 111,106 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $253,000 | -20.7% | 110,631 | +0.7% | 0.00% | 0.0% |
Q2 2014 | $319,000 | – | 109,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 5,663,845 | $21,013,000 | 1.13% |
HealthCor Management, L.P. | 1,335,000 | $4,953,000 | 0.25% |
Baker Brothers Advisors | 6,970,902 | $25,862,000 | 0.23% |
Palo Alto Investors LP | 1,226,748 | $4,551,000 | 0.20% |
WALL STREET ASSOCIATES | 500,000 | $1,855,000 | 0.18% |
NATIXIS | 3,148,916 | $11,682,000 | 0.16% |
MYCIO WEALTH PARTNERS, LLC | 200,000 | $742,000 | 0.14% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $1,379,000 | 0.12% |
HOLLENCREST CAPITAL MANAGEMENT | 177,570 | $659,000 | 0.10% |
CARL DOMINO INC | 32,137 | $119,000 | 0.08% |